216 related articles for article (PubMed ID: 21069311)
1. Prevention of renal crystal deposition by an extract of Ammi visnaga L. and its constituents khellin and visnagin in hyperoxaluric rats.
Vanachayangkul P; Chow N; Khan SR; Butterweck V
Urol Res; 2011 Jun; 39(3):189-95. PubMed ID: 21069311
[TBL] [Abstract][Full Text] [Related]
2. An aqueous extract of Ammi visnaga fruits and its constituents khellin and visnagin prevent cell damage caused by oxalate in renal epithelial cells.
Vanachayangkul P; Byer K; Khan S; Butterweck V
Phytomedicine; 2010 Jul; 17(8-9):653-8. PubMed ID: 20036111
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic evaluation of visnagin and Ammi visnaga aqueous extract after oral administration in rats.
Haug KG; Weber B; Hochhaus G; Butterweck V
Planta Med; 2012 Nov; 78(17):1831-6. PubMed ID: 23096256
[TBL] [Abstract][Full Text] [Related]
4. Assessment of Conventional Solvent Extraction vs. Supercritical Fluid Extraction of Khella (
Khalil N; Bishr M; El-Degwy M; Abdelhady M; Amin M; Salama O
Molecules; 2021 Feb; 26(5):. PubMed ID: 33673560
[TBL] [Abstract][Full Text] [Related]
5. Nonlinear pharmacokinetics of visnagin in rats after intravenous bolus administration.
Haug KG; Weber B; Hochhaus G; Butterweck V
Eur J Pharm Sci; 2012 Jan; 45(1-2):79-89. PubMed ID: 22085634
[TBL] [Abstract][Full Text] [Related]
6. Determination of khellin and visnagin in Ammi visnaga fruits by capillary electrophoresis.
Günaydin K; Erim FB
J Chromatogr A; 2002 Apr; 954(1-2):291-4. PubMed ID: 12058914
[TBL] [Abstract][Full Text] [Related]
7. Validated HPLC method for simultaneous estimation of khellol glucoside, khellin and visnagin in Ammi visnaga L. fruits and pharmaceutical preparations.
Badr JM; Hadad GM; Nahriry K; Hassanean HA
Nat Prod Res; 2015; 29(7):593-601. PubMed ID: 25111086
[TBL] [Abstract][Full Text] [Related]
8. A polyherbal formulation attenuates hyperoxaluria-induced oxidative stress and prevents subsequent deposition of calcium oxalate crystals and renal cell injury in rat kidneys.
Bodakhe KS; Namdeo KP; Patra KC; Machwal L; Pareta SK
Chin J Nat Med; 2013 Sep; 11(5):466-71. PubMed ID: 24359768
[TBL] [Abstract][Full Text] [Related]
9. Khellin and Visnagin, Furanochromones from Ammi visnaga (L.) Lam., as Potential Bioherbicides.
Travaini ML; Sosa GM; Ceccarelli EA; Walter H; Cantrell CL; Carrillo NJ; Dayan FE; Meepagala KM; Duke SO
J Agric Food Chem; 2016 Dec; 64(50):9475-9487. PubMed ID: 27936681
[TBL] [Abstract][Full Text] [Related]
10. Larvicidal activity of extracts from Ammi visnaga Linn. (Apiaceae) seeds against Culex quinquefasciatus Say. (Diptera: Culicidae).
Pavela R; Vrchotová N; Tříska J
Exp Parasitol; 2016 Jun; 165():51-7. PubMed ID: 26995534
[TBL] [Abstract][Full Text] [Related]
11. Exploring the multifaceted effects of
Ndayambaje M; Wahnou H; Sow M; Chgari O; Habyarimana T; Karkouri M; Limami Y; Naya A; Oudghiri M
J Toxicol Environ Health A; 2024 Feb; 87(4):150-165. PubMed ID: 38037686
[No Abstract] [Full Text] [Related]
12. Effect of NADPH oxidase inhibition on the expression of kidney injury molecule and calcium oxalate crystal deposition in hydroxy-L-proline-induced hyperoxaluria in the male Sprague-Dawley rats.
Zuo J; Khan A; Glenton PA; Khan SR
Nephrol Dial Transplant; 2011 Jun; 26(6):1785-96. PubMed ID: 21378157
[TBL] [Abstract][Full Text] [Related]
13. Spontaneous stone passage: is it Ammi visnaga effect?
Kilicaslan I; Coskun S
Urol Res; 2012 Dec; 40(6):799-800. PubMed ID: 22990409
[TBL] [Abstract][Full Text] [Related]
14. Khellin and visnagin in different organs of
Adımcılar V; Beyazit N; Erim FB
Nat Prod Res; 2023 Jan; 37(1):164-166. PubMed ID: 34569361
[No Abstract] [Full Text] [Related]
15. Curative treatment with extracts of Bombax ceiba fruit reduces risk of calcium oxalate urolithiasis in rats.
Gadge NB; Jalalpure SS
Pharm Biol; 2012 Mar; 50(3):310-7. PubMed ID: 22321032
[TBL] [Abstract][Full Text] [Related]
16. Minipump induced hyperoxaluria and crystal deposition in rats: a model for calcium oxalate urolithiasis.
Marengo SR; Chen D; MacLennan GT; Resnick MI; Jacobs GH
J Urol; 2004 Mar; 171(3):1304-8. PubMed ID: 14767338
[TBL] [Abstract][Full Text] [Related]
17. Study of a rat model for calcium oxalate crystal formation without severe renal damage in selected conditions.
Yamaguchi S; Wiessner JH; Hasegawa AT; Hung LY; Mandel GS; Mandel NS
Int J Urol; 2005 Mar; 12(3):290-8. PubMed ID: 15828958
[TBL] [Abstract][Full Text] [Related]
18. Vitamin E therapy prevents hyperoxaluria-induced calcium oxalate crystal deposition in the kidney by improving renal tissue antioxidant status.
Thamilselvan S; Menon M
BJU Int; 2005 Jul; 96(1):117-26. PubMed ID: 15963133
[TBL] [Abstract][Full Text] [Related]
19. Prophylactic effects of quercetin and hyperoside in a calcium oxalate stone forming rat model.
Zhu W; Xu YF; Feng Y; Peng B; Che JP; Liu M; Zheng JH
Urolithiasis; 2014 Dec; 42(6):519-26. PubMed ID: 25085199
[TBL] [Abstract][Full Text] [Related]
20. Effect of angiotensin II receptor blockage on osteopontin expression and calcium oxalate crystal deposition in rat kidneys.
Umekawa T; Hatanaka Y; Kurita T; Khan SR
J Am Soc Nephrol; 2004 Mar; 15(3):635-44. PubMed ID: 14978165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
